星昊医药：关于完成工商变更登记及公司章程备案并取得营业执照的公告

Core Viewpoint - Xinghao Pharmaceutical announced a reduction in its registered capital and the completion of related business registration changes [2] Group 1: Company Actions - The company will hold its fifth extraordinary general meeting of shareholders on November 13, 2025, to review and approve the proposal for reducing registered capital and amending business registration [2] - The registered capital has been reduced from 124.9612 million to 124.83228 million [2] - The company has completed the necessary business registration changes and obtained a new business license from the Beijing Economic and Technological Development Zone Market Supervision Administration [2]